Nisa Investment Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

$15.2 Billion
Q1 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 8,155 shares of ALNY stock, worth $2.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,155

Previous 8,155 -0.0%

Holding current value

$2.03 Million

Previous $1.56 Million 21.92%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $407,022 - $466,510	-2,200 Reduced 21.25%	8,155 $1.55 Million
Q1 2023 May 02, 2023	SELL	$182.66 - $235.53 $4,566 - $5,888	-25 Reduced 0.24%	10,355 $2.07 Million
Q3 2022 Nov 07, 2022	SELL	$138.54 - $232.0 $48,904 - $81,896	-353 Reduced 3.29%	10,380 $2.09 Million
Q2 2022 Aug 03, 2022	BUY	$120.42 - $169.29 $355,239 - $499,405	2,950 Added 37.9%	10,733 $1.57 Million
Q1 2022 Apr 29, 2022	SELL	$127.18 - $173.91 $125,145 - $171,127	-984 Reduced 11.22%	7,783 $1.27 Million

Q4 2021 Feb 03, 2022	SELL	$159.56 - $209.29 $3.47 Million - $4.55 Million	-21,760 Reduced 71.28%	8,767 $1.21 Million
Q3 2021 Oct 18, 2021	BUY	$169.75 - $207.73 $2.96 Million - $3.62 Million	17,415 Added 132.82%	30,527 $5.76 Million
Q2 2021 Aug 06, 2021	SELL	$128.63 - $176.89 $2.3 Million - $3.17 Million	-17,900 Reduced 57.72%	13,112 $2.22 Million
Q1 2021 Apr 26, 2021	BUY	$126.83 - $175.69 $1.99 Million - $2.76 Million	15,700 Added 102.53%	31,012 $4.38 Million
Q4 2020 Jan 25, 2021	BUY	$122.97 - $147.0 $352,923 - $421,890	2,870 Added 23.07%	15,312 $1.99 Million
Q3 2020 Oct 20, 2020	SELL	$121.19 - $165.49 $535,175 - $730,803	-4,416 Reduced 26.2%	12,442 $1.81 Million
Q2 2020 Jul 27, 2020	BUY	$104.21 - $156.44 $456,231 - $684,894	4,378 Added 35.08%	16,858 $2.5 Million
Q1 2020 Apr 17, 2020	BUY	$93.12 - $133.99 $186,240 - $267,980	2,000 Added 19.08%	12,480 $1.36 Million
Q4 2019 Jan 17, 2020	SELL	$74.51 - $124.23 $2.24 Million - $3.73 Million	-30,000 Reduced 74.11%	10,480 $1.21 Million
Q3 2019 Oct 17, 2019	BUY	$70.9 - $87.82 $2.35 Million - $2.91 Million	33,132 Added 450.9%	40,480 $3.26 Million
Q2 2019 Jul 12, 2019	SELL	$65.86 - $92.79 $285,503 - $402,244	-4,335 Reduced 37.11%	7,348 $533,000
Q1 2019 Apr 17, 2019	BUY	$72.76 - $93.45 $164,364 - $211,103	2,259 Added 23.97%	11,683 $1.09 Million
Q4 2018 Jan 17, 2019	SELL	$62.67 - $88.33 $25,068 - $35,332	-400 Reduced 4.07%	9,424 $687,000
Q3 2018 Oct 16, 2018	BUY	$87.52 - $122.67 $190,268 - $266,684	2,174 Added 28.42%	9,824 $860,000
Q2 2018 Jul 19, 2018	BUY	$88.31 - $107.8 $543,106 - $662,970	6,150 Added 410.0%	7,650 $753,000
Q1 2018 Apr 10, 2018	SELL	$115.92 - $148.54 $660,744 - $846,678	-5,700 Reduced 79.17%	1,500 $179,000
Q4 2017 Jan 12, 2018	BUY	$114.49 - $139.98 $80,143 - $97,986	700 Added 10.77%	7,200 $915,000
Q3 2017 Oct 13, 2017	BUY	$72.53 - $118.27 $471,445 - $768,755	6,500	6,500 $764,000

Others Institutions Holding ALNY

# of Institutions

585

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History